RCMI Coordinating Center (RCMI CC) Header Logo

Amosy M'Koma

TitleMD/ Physician Scientist
Faculty RankAssociate Professor
InstitutionMeharry Medical College
DepartmentBiochem, Cancer Biology, Neuroscience & Pharmacology
AddressMMC, 1005 Dr. D. B. Todd Jr. Boulevard
VICC, Vanderbilt-Ingram Cancer Center
Nashville TN 37208
Phone6153276796
Fax6153276442
vCardDownload vCard
    Other Positions
    TitleAssociate Professor of Surgery
    InstitutionVanderbilt University Medical Center
    DepartmentGeneral Surgery

    TitleAffiliated Scientific Investigator
    InstitutionAmerican Society of Colon and Rectal Surgeons
    DepartmentColon and Rectal Surgery

    TitleMember
    InstitutionAmerican Gastroenterological Association
    DepartmentGastroenterolog

    TitleEditorial Board
    InstitutionWorld Journal of Surgical Procedures
    DepartmentSurgery


    Collapse Biography 
    Collapse education and training
    Kharkov Medical Institute, UKRAINEMD1984Medicine
    Karolinska Hospital, Huddinge, SWEDENResidency1990Surgery, General
    Karolinska Nobel Institute, SWEDENLicentiate1999Surgery, Clinical, Colon & Rectum
    Karolinska Nobel Institute, SWEDENPhD2001Surgery, Clinical, Colon & Rectum
    Mayo Clinic, Rochester, MN, U.S.AFellow2004Surgery, Research, Colon & Rectum
    Vanderbilt Univ Med Center, TN, U.S.APostDoc2007Surgery, Urologic & Cancer Biology
    Collapse awards and honors
    2012 - 2012AACR Minority Serving Institution Faculty Scholar in Cancer Research, American Association for Cancer Research
    2011 - 2011AACR Minority Serving Institution Faculty Scholar in Cancer Research, American Association for Cancer Research
    2011 - 2016The Early Detection Research Network (EDRN), Data Management Center (DMCC), National Institute of Health/NCI
    2009 - 2009The New Jersey Society of Colon and Rectal Surgeons, Best Basic Science Presentation Poster , American Society of Colon and Rectal Surgeons
    2009 - 2010Research Foundation’s 2009 LPG Grant, American Society of Colon and Rectal Surgeons
    2009 - 2016Affiliated Scientific Investigator, American Society of Colon and Rectal Surgeons
    2005 - 2007K12 - Institutional Research and Academic Career Development (IRACDA), NIH/NIGMS
    2010 - 2013Clinical and Translational Research in GI, NIH/CTSA/ The Vanderbilt Institute for Clinical and Translational Research (VICTR)
    1999 - 2003Swedish Committee of Inquiry into HIV/AIDS (Statens offentliga utredningar, S 2002:11), Swedish Government
    1999 - 2003Partenariat Européen entre communautés africaines, European Union, DGV
    1999 - 2002Migration and Health issues, Swedish Institute of Public Health
    2014 - 2016 Membership Committee: Recommends member categories and criteria to the Executive Council worldwide, American Society of Colon and Rectal Surgeons
    2015 - 2015Recognition of Research: Physiology of restorative proctocolectomy and ileal pouch-anal anastomosis, World Journal of Surgical Procedures
    2016 - 2016The New England Society of Colon and Rectal Surgeons, Best Clinical Podium Presentation, American Society of Colon and Rectal Surgeons
    2013 - 2015R21 DK095186: Differentiating Ulcerative Colitis and Crohns Colitis Through Proteomic Patterns, NIH/NIDDK
    2017 - 2020Vice-Chair-Institutional Review Board (IRB), Meharry Medical College School of Medicine
    2020 - 2022Chair - Institutional Review Board (IRB), Meharry Medical College School of Medicine
    2020US Patent - Methods for Diagnosing & Treating IBD (16/571,034,2020), Meharry Medical College (SOM)
    2020US Patent - Targeted DEFA5 antibody and assay methods for diagnosing & treating IBD (WO2018237064A1), Meharry Medical College School of Medicine
    2019 - 2022American Society of Colon & Rectal Surgeons-ASCRS IBD Committee: Promotes adoption of best practices, The American Society of Colon & Rectal Surgerons
    2020 - 2022Pilot Project in the GI SPORE Career Enhancement Award, Vanderbilt Ingram-Cancer Center (VICC)

    Collapse Overview 
    Collapse overview


    Amosy E. M'Koma is a tenured full professor of Surgery, Surgical Sciences, Pathology, and Cancer Biology at the Schools of Medicine, Meharry Medical College, and Vanderbilt University Medical Center, Division of General Surgery and Surgical Sciences, Section of Colon and Rectal Surgery. Dr. M'Koma's laboratory specializes in predominantly colonic inflammatory bowel disease (IBD), i.e., ulcerative colitis (UC), Crohn’s colitis (CC), and indeterminate colitis (IC) when the established criteria for UC and CC are non-definitive and IBD-associated colorectal cancer (CRC) research. His particular keen specialty is on molecular diagnostic methodologies and surgical management of IBD, specifically as they relate to the physiology of pouch surgery, restorative proctocolectomy, and ileal pouch-anal anastomosis (RPC-IPAA). For years he has been investigating the physiology and metabolic biochemical variable events following surgical treatment of the UC and familial adenomatous polyposis (FAP), the RPC-IPAA. The successful outcomes of pouch surgery and recovery depend on the correct diagnosis. M'Koma's objective is to develop a diagnostic ‘Gold Standard” bioassay tool that is Affordable, Sensitive, Specific, User-friendly, Robust and Rapid, Equipment-free, and Deliverable (ASSURED) to the end-user during the first clinic endoscopy biopsy procedural visit without delay. An accurate diagnosis before initiating medical therapy or performing colectomy and construction of RPC-IPAA is paramount in terms of evidenced personalized medical treatment, surgical intervention, and prognosis, as well as delineation of IBD by non-invasive, easier, affordable, accurate, and faster screening. We anticipate these studies will provide hitherto unclear diagnostic sites that may be exploited for therapeutic purposes. We use patient-known clinical data to correlate with their endoscopy biopsy data. This will be the true test of diagnostic utility. The project performs proteomic analyses from authentic UC and CC to develop an ASSURED signature that discriminates between UC and CC patients and also predicts the outcome of IC patients for their eventual progress to either authentic UC or CC. Based on our current data, we have identified several biomarkers of interest that may delineate the IBD subtypes in endoscopic biopsies. In the future, we plan to explore the use of one or more of these biosignatures as a serum biomarker if the signature(s) uncovered are (are) secretory and transposable. In addition, over the past years, M'Koma has established a translational research program in biomarker discoveries focused on the Early Detection of IBD-associated colorectal malignancy in collaboration with NIH-funded Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer (VICC GI SPORE).

    Collapse Research 
    Collapse research activities and funding
    R21DK095186     (M'KOMA, AMOSY EPHREIM)Aug 1, 2013 - Jul 31, 2016
    NIH
    Differentiating Ulcerative Colitis and Crohns Colitis Through Proteomic Patterns
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thangaiyan R, Sakwe AM, Hawkins AT, Washington MK, Ballard BR, Izban MG, Chirwa SS, Hildreth JEK, Shanker A, Blum DL, M'Koma AE. Anti-DEFA5 Monoclonal Antibody Clones 1A8 and 4F5 Immunoreactive Bioassay for Diagnosing Inflammatory Bowel Disease. Res Sq. 2024 Aug 29. PMID: 39257990.
      Citations:    
    2. Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, Sakwe AM, Nian H, Wang L, Yu C, Goodwin JS, Izban MG, Offodile RS, Washington MK, Ballard BR, Smoot DT, Shi XZ, Forbes DS, Shanker A, M'Koma AE. Correction: Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PLoS One. 2024; 19(5):e0304732. PMID: 38809824.
      Citations:    Fields:    
    3. Hajri T, Gharib M, Fungwe T, M'Koma A. Very low-density lipoprotein receptor mediates triglyceride-rich lipoprotein-induced oxidative stress and insulin resistance. Am J Physiol Heart Circ Physiol. 2024 May 24. PMID: 38787383.
      Citations:    Fields:    
    4. William A. Breaux, Maya A. Bragg, Amosy E. M'Koma. Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn’s Colitis among Indeterminate Colitis Cohorts. Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn’s Colitis among Indeterminate Colitis Cohorts. 2023; 11(8). View Publication.
    5. Reference Citation Analysis (RCA). Reference Citation Analysis (RCA). 2023. View Publication.
    6. William A. Breaux, Maya A. Bragg, Amosy E. M'Koma*. Ubiquitous Colonic Ileal Metaplasia Consistent with Crohn's Colitis among Indeterminate Colitis Cohorts. Med Res Arch. 2023; 1(11):1-12. View Publication.
    7. Breaux WA, Bragg MA, M'Koma AE. Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn's Colitis among Indeterminate Colitis Cohorts. Med Res Arch. 2023 Aug; 11(8). PMID: 37854669.
      Citations:    
    8. Johnson JC, Geesala R, Zhang K, Lin YM, M'Koma AE, Shi XZ. Smooth muscle dysfunction in the pre-inflammation site in stenotic Crohn's-like colitis: implication of mechanical stress in bowel dysfunction in gut inflammation. Front Physiol. 2023; 14:1215900. PMID: 37520831.
      Citations:    
    9. John C. Johnson, Ramasatyaveni Geesala, Ke Zhang, You-Min Lin, Amosy E. M'Koma, Xuan-Zheng P. Shi. Smooth Muscle Dysfunction in the Pre-inflammation Site in Stenotic Crohn's-like Colitis: Implication of Mechanical Stress in Bowel Dysfunction in Gut Inflammation. Front. Physiol. 14:1215900. 2023; (14):1215900.. View Publication.
    10. Maya A. Bragg, William A. Breaux, Amosy E. M'Koma. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, a By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis. Medicina. 2023; 7(59):1254. View Publication.
    11. Baishideng Publishing Group Inc. Baishideng Quality Journal. World Journals-Baishideng. 2023. View Publication.
    12. Bragg MA, Breaux WA, M'Koma AE. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis. Medicina (Kaunas). 2023 07; 59(7). PMID: 37476546.
      Citations:    Fields:    Translation:HumansCells
    13. Amosy E. M'Koma*, Jamie N. Ware, Rosemary K. Nabaweesi, Sanika S. Chirwa. Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood. Med Res Arch. 2023; 11(6):1-27. View Publication.
    14. M'Koma AE, Ware JN, Nabaweesi RK, Chirwa SS. Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood. Med Res Arch. 2023 Jun; 11(6). PMID: 37492395.
      Citations:    
    15. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management. Med Res Arch. 2023 Jan; 11(1). PMID: 37089816.
      Citations:    
    16. Amosy M'Koma Featured on the Cover Story of World Journal of Gastrointestinal Endoscopy. 2023; 15(1):1948-5190. View Publication.
    17. Amosy M'Koma. Methods for diagnosing and treating inflammatory bowel disease. 2022. View Publication.
    18. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina (Kaunas). 2022 Apr 21; 58(5). PMID: 35629984.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    19. M'Koma AE, Sakwe AM. Targeted HD5 antibody and assay methods for diagnosing and treating inflammatory bowel disease. 2021. View Publication.
    20. Lin YM, Qiu S, M'Koma AE, Powell DW, Cohn S, Shi XZ. Sa130 Mechanical stress plays a critical role in intestinal fibrosis and smooth muscle hyperplasia in a rodent model of Crohn's disease. Gastroenterology. 2021; 6(160):S-431. View Publication.
    21. M'Koma AE. The diagnostic potential of human alpha defensin 5 in inflammatory bowel disease. Disease of the Colon & Rectum. 2021; 64(5). View Publication.
    22. Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, Sakwe AM, Hui N, Wang L, Yu C, Goodwin JS, Izban MG, Offodile RS, Washington MK, Ballard BR, Smoot DT, Shi XZ, Forbes DS, Shanker A, M'Koma AE. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PLoS One. 2021; 16(3):e0246393. PMID: 33690604.
      Citations: 11     Fields:    Translation:HumansCells
    23. M'Koma AE. Methods for Diagnosing and Treating Inflammatory Bowel Disease. 2020. View Publication.
    24. Herman AM, Hawkins AT, James SD, Ballard BR, M'Koma AE. Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations. 2020; 2(3):1-11. View Publication.
    25. James SD, Hawkins AT, Um JW, Ballard BR, Smoot DT, M'Koma AE. The MYTHS of De novo Crohn's Disease After Restorative Proc-tocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative colitis. 2020; 2(3):1-10. View Publication.
    26. James SD, Hawkins AT, Um JW, Ballard BR, Smoot DT, M'Koma AE. The MYTHS of De novo Crohn's Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis. Jpn J Gastroenterol Hepatol. 2020; 3(2). PMID: 37584007.
      Citations:    
    27. Herman AM, Hawkins AT, James SD, Ballard BR, M'Koma AE. Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations. Jpn J Gastroenterol Hepatol. 2020; 3(2). PMID: 37615012.
      Citations:    
    28. M'Koma AE. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointest Disord (Basel). 2019 Mar; 1(1):75-105. PMID: 37577036.
      Citations:    
    29. Amosy E. M'Koma. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. 2018; 1(1):75-105. View Publication.
    30. James SD, Hawkins AT, M'Koma AE. Adenocarcinoma at the Ileostomy Site After a Proctocolectomy for Ulcerative Colitis and/or Familial Adenomatous Polyposis: An Overview. 2018; 6(64):30-40. View Publication.
    31. Hawkins AT, Um JW, M'Koma AE. Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis. Clin Med Insights Gastroenterol. 2017; 10:1179552217746692. PMID: 29276421.
      Citations:    
    32. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE. Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS One. 2017; 12(12):e0189551. PMID: 29211779.
      Citations:    Fields:    
    33. M'Koma AE. Inflammatory Bowel Disease. State-of-the-Art Performance Improvements After Restorative Proctocolectomy for Ulcerative Colitis: Thirty-Year-Benchmark Evaluation. 2017; 1-45. View Publication.
    34. M'Koma AE. Editorial. Editorial Policies and Skills to Solving Diagnostic Delay in Inflammatory Bowel Disease. 2017; 1(1):1. View Publication.
    35. Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS One. 2017; 12(8):e0179710. PMID: 28817680.
      Citations: 20     Fields:    Translation:Humans
    36. Hawkins AT, Um JW, M'Koma AE. Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis. Original Article. 2017; 1179552217746692. View Publication.
    37. Williams AD, M'Koma AE. Clinics in Surgery. Delineation of inflammatory bowel disease by molecular biometrics: verification versus validation. 2017; (2):1408. View Publication.
    38. Ballard BR, M'Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn’s colitis. World J Gastrointest Endosc. 2015; 7(7):670-674. View Publication.
    39. Ballard BR, M'Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis. World J Gastrointest Endosc. 2015 Jun 25; 7(7):670-4. PMID: 26140094.
      Citations:    
    40. Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015; 8:29-44. PMID: 26078592.
      Citations:    
    41. Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015; 8:29-44. View Publication.
    42. World Journal of Surgical Procedures. Baishideng Publishing Group Inc. Amosy M'Koma Featured on the Cover Story of World Journal of Surgical Procedures. 2015; 1-176. View Publication.
    43. M'Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. e-Book: World Clinical Inflammatory Bowel Disease. 2015; 1-1215. View Publication.
    44. M'Koma AE. Mucosal Derived Proteomic Patterns Predict Indeterminate into Ulcerative and Crohn’s Colitides. 3rd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics. 2015. View Publication.
    45. Vaiopoulou A, Gazouli M, Papadopoulou A, Anagnostopoulos AK, Karamanolis G, Theodoropoulos GE, M'Koma A, Tsangaris GT. Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr. 2015 Jan; 60(1):42-7. PMID: 25250685.
      Citations: 10     Fields:    Translation:Humans
    46. M'Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg. 2014 Nov 27; 6(11):208-19. PMID: 25429322.
      Citations:    
    47. M'Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg. 2014; 6(11):208-219. View Publication.
    48. Myers JN, Sch?ffer MW, Korolkova OY, Williams AD, Gangula PR, M'Koma AE. Implications of the colonic deposition of free hemoglobin-a chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis. 2014 09; 20(9):1530-47. PMID: 25078150.
      Citations: 13     Fields:    Translation:Humans
    49. M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis. 2014; 5(26):533-552. View Publication.
    50. M'Koma AE, Herline AJ, Adunyah SE. Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis. World Journal of Colorectal Surgery. 2013; 3(2):1. View Publication.
    51. Seeley EH, Washington MK, Caprioli RM, M'Koma AE. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl. 2013; 7-8(7):541-9. View Publication.
    52. Seeley EH, Washington MK, Caprioli RM, M'Koma AE. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl. 2013 Aug; 7(7-8):541-9. PMID: 23382084.
      Citations: 32     Fields:    Translation:Humans
    53. Smith JC, Schäffer MW, Ballard BR, Smoot DT, Herline AJ, Adunyah SE, M'Koma AE. Adenocarcinomas after Prophylactic Surgery for Familial Adenomatous Polyposis. Journal of Cancer Research. 2013; 4(1):260-270. View Publication.
    54. M'Koma AE. Inflammatory Bowel Disease: An Expanding Global Health Problem. Clin Med Insights. 2013; 6:33-47. View Publication.
    55. M'Koma AE, Herline AJ, Adunyah SE. Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis. World J Colorectal Surg. 2013; 3(2). PMID: 24817992.
      Citations:    
    56. M'Koma AE. Letter to Editor. Adv Enzyme Res. 2013; 1(4):77-78. PMID: 25664328.
      Citations:    
    57. Um JW, M'Koma AE. Dysplasie und Adenokarzinome im Ileum-Pouch nach restaurativer Proctokolectomie wegen Colitis ulcerosa. Coloproctology. 2011; 33(5): 273-282. View Publication.
    58. M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis. 2011 May; 26(5):533-52. PMID: 21311893.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    59. Um JW, M'Koma AE. Pouch-related dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Tech Coloproctol. 2011 Mar; 15(1):7-16. PMID: 21287223.
      Citations: 10     Fields:    Translation:Humans
    60. M'Koma AE, Seeley EH, Washington MK, Schwartz DA, Muldoon RL, Herline AJ, Wise PE, Caprioli RM. Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflamm Bowel Dis. 2011 Apr; 17(4):875-83. PMID: 20806340.
      Citations: 41     Fields:    Translation:Humans
    61. M'Koma AE. Biochemical Laboratory Data Following Restorative Proctocolectomy: Observations on Essential Biochemical Data Profile in Connection with Restorative Proctocolectomy in Humans. LAP Lambert Academic Publishing. 2010; 140. View Publication.
    62. M'Koma AE, Wise PE, Seeley EH, Schwartz DA, Washington MK, Muldoon RL, El-Rifai WM, Herline AJ. Gene Expression of Colonic Submucosa Differs Between the Inflammatory Colitides. Annual Congress - The American Society of Colon and Rectal Surgeons. 2010; 117.
    63. M'Koma AE, Wise PE, Seeley EH, Washington MK, Schwartz DA, Muldoon RL, Herline AJ, Caprioli RM. Human Alpha-Defensins are Differentially Expressed Between the Inflammatory Colitides. Gastroenterology. 2010; 138:S-525.
    64. M'Koma AE, Wise PE, Schwartz DA, Muldoon RL, Herline AJ. Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis Colon Rectum. 2009 Apr; 52(4):726-39. PMID: 19404082.
      Citations: 10     Fields:    Translation:Humans
    65. M'Koma AE, Seeley EH, Wise PE, Washington MK, Schwartz DA, Caprioli RM, Muldoon RL, Herline AJ. Proteomic Patterns of Colonic Submucosa Discriminates Inflammatory Colitides. Annual Congress - The American Society of Colon and Rectal Surgeons. 2009; 166.
    66. M'Koma AE, Seeley EH, Wise PE, Washington MK, Schwartz DA, Herline AJ, Muldoon RL, Caprioli RM. Proteomic analysis of colonic submucosa differentiates Crohn's and ulcerative colitis. Annual Congress - Digestive Disease Week. 2009; P600:M1096. View Publication.
    67. Blum DL, Koyama T, M'Koma AE, Iturregui JM, Martinez-Ferrer M, Uwamariya C, Smith JA, Clark PE, Bhowmick NA. Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin Cancer Res. 2008 Dec 01; 14(23):7790-7. PMID: 19047106.
      Citations: 26     Fields:    Translation:Humans
    68. M'Koma AE, Wise PE, Muldoon RL, Schwartz DA, Washington MK, Herline AJ. Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones. Int J Colorectal Dis. 2007 Oct; 22(10):1143-63. PMID: 17576578.
      Citations: 17     Fields:    Translation:Humans
    69. M'Koma AE, Blum DL, Norris JL, Koyama T, Billheimer D, Motley S, Ghiassi M, Ferdowsi N, Bhowmick I, Chang SS, Fowke JH, Caprioli RM, Bhowmick NA. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem Biophys Res Commun. 2007 Feb 16; 353(3):829-34. PMID: 17194448.
      Citations: 27     Fields:    Translation:Humans
    70. M'Koma AE, Longo WE. Postoperative liver enzyme abnormalities are related to staged restorative proctocolectomy. Int J Colorectal Dis. 2007 Mar; 22(3):283-8. PMID: 16583192.
      Citations: 2     Fields:    Translation:Humans
    71. M'Koma AE. Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. Int J Colorectal Dis. 2006 Oct; 21(7):711-20. PMID: 16437210.
      Citations: 12     Fields:    Translation:Humans
    72. M'Koma AE. Observations on Essential Biochemical Data Profile in Connection with Restorative Proctocolectomy in Humans. 2001. View Publication.
    73. M'Koma AE, Lindquist K, Liljeqvist L. A study of plasma immunoglobulins profile in connection with restorative proctocolectomy. Int J Surg Investig. 2000; 2(2):125-31. PMID: 12678510.
      Citations: 4     Fields:    Translation:Humans
    74. M'Koma AE, Lindquist K, Liljeqvist L. Observations in the blood lipid profile in patients undergoing restorative proctocolectomy. Int J Surg Investig. 2000; 2(3):227-35. PMID: 12678523.
      Citations: 4     Fields:    Translation:Humans
    75. M'Koma AE, Lindquist K, Liljeqvist L. Effect of restorative proctocolectomy on gastric acid secretion and serum gastrin levels: a prospective study. Dis Colon Rectum. 1999 Mar; 42(3):398-402. PMID: 10223764.
      Citations: 6     Fields:    Translation:Humans
    76. Amosy E. M'Koma . Original Resarch. Observations on Biochemical Data in Connection with Restorative Proctocolectomy [An analysis with specific reference to lipoproteins and gastric acids]. 1999; 8(12):e017910. View Publication.
    77. M'Koma AE. Follow-up results of hematology data before and after restorative proctocolectomy. Clinical outcome. Dis Colon Rectum. 1994 Sep; 37(9):932-7. PMID: 8076494.
      Citations: 11     Fields:    Translation:Humans
    78. M'Koma AE, Lindquist K, Liljeqvist L. Biochemical laboratory data in patients before and after restorative proctocolectomy. A study on 83 patients with a follow-up of 36 months. Ann Chir. 1994; 48(6):525-34. PMID: 7847701.
      Citations: 7     Fields:    Translation:Humans
    M'Koma's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (124)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support